Continuous interleukin‐2 and tumor‐infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial
Robert O. Dillman, Neil M. Barth, Robert K. Oldham, Richard J. Cohen, David R. Minor, Robert Birch, Jerri Arnold, John R. Yannelli, James R. Maleckar, Anthony Sferruzza, William H. West
Research output: Contribution to journal › Article › peer-review
103Scopus
citations
Fingerprint
Dive into the research topics of 'Continuous interleukin‐2 and tumor‐infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial'. Together they form a unique fingerprint.